These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 5799558)
1. On the pharmacology of a benzoquinolizine derivative: Ro 4-1284. Vidal-Beretervide K; Trinidad H; Pritsch LE Pharmacology; 1969; 2(2):113-23. PubMed ID: 5799558 [No Abstract] [Full Text] [Related]
2. The pharmacology of N, -dimethyl-N- -chloroethylphenethylamine. Hci--effects on the autonomic nervous system. Dóda M; György L; Pfeifer AK; Zára-Kaczián E; Fodor M Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):280-7. PubMed ID: 4401082 [No Abstract] [Full Text] [Related]
3. On the pharmacology of guanoxan. Vidal-Beretervide K; Pritsch LE; Trinidad H Arzneimittelforschung; 1969 Jun; 19(6):947-51. PubMed ID: 4389903 [No Abstract] [Full Text] [Related]
4. Antagonism of ganglionic stimulants by alpha, alpha'-bis-(dimethylammoniumacetaldehyde diethylacetal)-p,p'-diacetylbiphenyl bromide (DMAE). Wong S; Long JP J Pharmacol Exp Ther; 1968 Nov; 164(1):176-84. PubMed ID: 5722100 [No Abstract] [Full Text] [Related]
5. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678). Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490 [No Abstract] [Full Text] [Related]
6. Effects of tetraphenylboron (TPB) on the autonomic nervous system. Guideri G; Seifter E; Seifter J Arch Int Pharmacodyn Ther; 1974 Apr; 208(2):224-34. PubMed ID: 4152865 [No Abstract] [Full Text] [Related]
7. The pharmacology of (4,4'-biphenylene-bis-(2-oxoethylene))-bis-((di-2-ethoxyethyl) methylammonium bromide) "DEO". Chiou CY; Long JP; Greenberg S; Shriver DA Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):29-42. PubMed ID: 4262838 [No Abstract] [Full Text] [Related]
8. Differential blockage and potentiation of transmission in a sympathetic ganglion. Kayaalp SO; McIsaac RJ J Pharmacol Exp Ther; 1970 May; 173(1):193-204. PubMed ID: 4315155 [No Abstract] [Full Text] [Related]
9. The mechanism of the peripheral vascular resistance change during exposure of dogs to bromotrifluoromethane. Van Stee EW; Back KC Toxicol Appl Pharmacol; 1972 Nov; 23(3):428-42. PubMed ID: 5085457 [No Abstract] [Full Text] [Related]
10. ON THE MECHANISM OF SENSIBILIZATION TO CATECHOLAMINES BY HEXONIUM (HEXAMETHONIUM). VITOLINA MA; MELZOBS MJ Int J Neuropharmacol; 1964 Apr; 3():141-5. PubMed ID: 14334591 [No Abstract] [Full Text] [Related]
11. Differential transmission in the superior cervical ganglion of the cat. Koss MC; Rieger JA J Pharmacol Exp Ther; 1976 Dec; 199(3):538-43. PubMed ID: 62832 [TBL] [Abstract][Full Text] [Related]
12. Late discharges in dog's sympathetic ganglia. Chen SS Can J Physiol Pharmacol; 1972 Mar; 50(3):263-9. PubMed ID: 4338065 [No Abstract] [Full Text] [Related]
13. Potentiation of catecholamines by a new diphenylalkanolamine. I. Studies in vivo and general pharmacology. Kasuya Y; Watanabe M Arzneimittelforschung; 1965 Nov; 15(11):1279-84. PubMed ID: 4382189 [No Abstract] [Full Text] [Related]
14. [Synthesis and pharmacodynamic properties of various lupinane derivatives]. Sparatore F; Boido V; Preziosi P; Miele E; De Natale G Farmaco Sci; 1969 Jun; 24(6):587-621. PubMed ID: 4390006 [No Abstract] [Full Text] [Related]
15. [Action of (N-piperidinomethyl)-5 coumarylamide on the ortho-sympathetic system]. Philippot E Arch Int Pharmacodyn Ther; 1967 Nov; 170(1):178-92. PubMed ID: 6070124 [No Abstract] [Full Text] [Related]